Astro-Med, Inc. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc., a manufacturer of medical and industrial instrumentation, for the period ended October 30, 1999. The company operates in three primary product groups: QuickLabel Systems (QLS), Grass Instruments, and Test & Measurement (T & M).
Key Financial Metrics
| Metric | Three Months Ended Oct 30, 1999 | Nine Months Ended Oct 30, 1999 |
|---|---|---|
| Net Sales | $11,044,728 | $32,506,666 |
| Gross Profit | $4,573,985 | $13,194,981 |
| Gross Margin | 41.4% | 40.6% |
| Operating Income | $427,086 | $110,827 |
| Net Income | $410,445 | $410,445 |
| Earnings Per Share (Diluted) | $0.09 | $0.09 |
| Cash and Equivalents | $4,473,503 | $4,473,503 (Ending Balance) |
| Working Capital | $24,763,000 | N/A |
| Current Ratio | 4.03 to 1 | N/A |
| Long-Term Debt | $132,038 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5% year-over-year for both the quarter and the nine-month period. Domestic sales rose 3% (quarter) and 2% (nine months), while export sales grew 10% (quarter) and 12% (nine months).
- Profitability: Operating income improved significantly to $427,086 in the quarter from $28,628 in the prior year quarter. For the nine months, the company turned an operating loss of $330,095 into a profit of $110,827.
- Margins: Gross profit margin improved to 41.4% in the quarter (from 40.8%) and 40.6% year-to-date (from 40.0%), driven by favorable product mix.
- Expenses: Operating expenses declined 3% in the quarter to $4,147,000, consuming 37.5 cents of every sales dollar compared to 40.6 cents in the prior year.
- Cash Flow: Net cash provided by operating activities was $1,701,017 for the nine months, a decrease from $2,024,126 in the prior year, primarily due to increases in accounts receivable and inventory.
Outlook, Risks, and Management Commentary
- Product Trends: QLS sales are up 17% and Grass Instruments up 6%. Test & Measurement sales remain behind prior year levels due to a slow recovery in aerospace markets, though recent trends are positive.
- Capital Allocation: The company continued its stock buyback program, purchasing 8,000 shares in the quarter. Management has approval to acquire an additional 242,000 shares. A quarterly dividend of $0.04 per share was declared.
- Year 2000 (Y2K) Readiness: The company estimates total Y2K remediation costs at approximately $806,000, with $649,000 already expended. The IT infrastructure is 100% complete, and the overall program is estimated at 85% complete as of October 30, 1999. Management expects completion by December 31, 1999.
- Risks: Key risks include general economic conditions, competitive pricing pressures, inventory risks, component shortages, and potential disruptions from third-party Y2K failures.
Investor Verification Checklist
- Verify the sustainability of the 5% sales growth, particularly the 10-12% export growth, given the volatility in international markets.
- Monitor the recovery of the Test & Measurement segment, which is currently lagging due to aerospace market conditions.
- Confirm the completion of the Year 2000 readiness program by the December 31, 1999 deadline and assess any potential costs from third-party supplier failures.
- Review the trend in accounts receivable (up 5% to $8.1M) and inventory (up 3% to $10.5M) to ensure they align with sales growth and do not indicate collection or obsolescence issues.
- Track the execution of the remaining stock buyback authorization (242,000 shares) and its impact on earnings per share.